Clusters of meningococcal disease illustrate differences in management of group B and C disease.
D000293:Adolescent; D002675:Child, Preschool; D004196:Disease Outbreaks / Q000517:prevention & control*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008297:Male; D008589:Meningococcal Infections / Q000453:epidemiology* / Q000382:microbiology / Q000517:prevention & control; D009345:Neisseria meningitidis / Q000145:classification / Q000302:isolation & purification*; D012293:Rifampin / Q000008:administration & dosage; D018805:Sepsis; D012703:Serotyping; D006113:United Kingdom / Q000453:epidemiology
D012293:Rifampin